A new report published by the the American Medical Association (AMA) finds that neither adult-use marijuana legalization nor the opening of retail stores in U.S. states...
A new federal study shows that enrollment in state-legal medical marijuana programs increased significantly across the U.S. in recent years. The researchers—from the Centers for Disease...
Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to...
A recently published analysis of smokable hemp products by researchers at the National Institute of Standards and Technology (NIST) found that the vast majority of samples–about...
A new scientific review highlights the potential of CBD to treat and manage the symptoms of conditions like epilepsy, pain, cancer, schizophrenia, diabetes and COVID-19, among...
Newly released data from a Washington State survey of adolescent and teenage students show declines in both lifetime and past-30-day marijuana use in recent years, with...
A new study funded by the National Institute on Drug Abuse (NIDA) has found that a citrusy-smelling terpene in marijuana could help ease anxiety and paranoia...